Published 16:22 IST, April 29th 2024
US FDA approves X4 Pharmaceuticals' therapy for rare immunodeficiency disease
The announcement led to a significant surge in X4 Pharmaceuticals' shares, which rose by 16% before the market opened on Monday.
US FDA | Image:
Reuters
- Listen to this article
- 2 min read
Advertisement
16:22 IST, April 29th 2024